Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1

被引：76

作者：

Kreijtz, Joost H. C. M. ^{[1
]}

Suezer, Yasemin ^{[1
]}

van Amerongen, Geert ^{[1
]}

de Mutsert, Gerrie ^{[1
]}

Schnierle, Barbara S. ^{[1
]}

Wood, John M. ^{[1
]}

Kuiken, Thijs ^{[1
]}

Fouchier, Ron A. M. ^{[1
]}

Loewer, Johannes ^{[1
]}

Osterhaus, Albert D. M. E. ^{[1
]}

Sutter, Gerd ^{[1
]}

Rimmelzwaan, Guus F. ^{[1
]}

机构：

[1] Erasmus MC, Dept Virol, NL-3000 DR Rotterdam, Netherlands

来源：

JOURNAL OF INFECTIOUS DISEASES | 2007年 / 195卷 / 11期

关键词：

D O I：

10.1086/517614

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Since 2003, the number of human cases of infections with highly pathogenic avian influenza viruses of the H5N1 subtype is still increasing, and, therefore, the development of safe and effective vaccines is considered a priority. However, the global production capacity of conventional vaccines is limited and insufficient for a worldwide vaccination campaign. In the present study, an alternative H5N1 vaccine candidate based on the replication-deficient modified vaccinia virus Ankara (MVA) was evaluated. C57BL/6J mice were immunized twice with MVA expressing the hemagglutinin (HA) gene from influenza virus A/Hongkong/156/97 (MVAHAHK/ 97) or A/Vietnam/ 1194/04 (MVA-HA-VN/ 04). Subsequently, recombinant MVA-induced protective immunity was assessed after challenge infection with 3 antigenically distinct strains of H5N1 influenza viruses: A/Hongkong/156/97, A/Vietnam/1194/04, and A/Indonesia/5/05. Our data suggest that recombinant MVA expressing the HA of influenza virus A/Vietnam/1194/04 is a promising alternative vaccine candidate that could be used for the induction of protective immunity against various H5N1 influenza strains.

引用

页码：1598 / 1606

页数：9

共 48 条

[31]

Palmer D., 1975, ADV LAB TECHNIQUES I, V6, P25

[32] Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro [J].

Rimmelzwaan, GF ;

Baars, M ;

Claas, ECJ ;

Osterhaus, ADME .

JOURNAL OF VIROLOGICAL METHODS, 1998, 74 (01) :57-66

[33] Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts [J].

Rimmelzwaan, GF ;

van Riel, D ;

Baars, M ;

Bestebroer, TM ;

van Amerongen, G ;

Fouchier, RAM ;

Osterhaus, ADME ;

Kuiken, T .

AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (01) :176-183

[34]

Staib Caroline, 2004, Methods Mol Biol, V269, P77

[35]

Stickl H, 1971, Munch Med Wochenschr, V113, P1149

[36] Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques [J].

Stittelaar, KJ ;

Kuiken, T ;

de Swart, RL ;

van Amerongen, G ;

Vos, HW ;

Niesters, HGM ;

van Schalkwijk, P ;

van der Kwast, T ;

Wyatt, LS ;

Moss, B ;

Osterhaus, ADME .

VACCINE, 2001, 19 (27) :3700-3709

[37] A RECOMBINANT VECTOR DERIVED FROM THE HOST RANGE-RESTRICTED AND HIGHLY ATTENUATED MVA STRAIN OF VACCINIA VIRUS STIMULATES PROTECTIVE IMMUNITY IN MICE TO INFLUENZA-VIRUS [J].

SUTTER, G ;

WYATT, LS ;

FOLEY, PL ;

BENNINK, JR ;

MOSS, B .

VACCINE, 1994, 12 (11) :1032-1040

[38] NONREPLICATING VACCINIA VECTOR EFFICIENTLY EXPRESSES RECOMBINANT GENES [J].

SUTTER, G ;

MOSS, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10847-10851

[39]

Sutter Gerd, 2003, Current Drug Targets - Infectious Disorders, V3, P263, DOI 10.2174/1568005033481123

[40] Avirulent avian influenza virus as a vaccine strain against a potential human pandemic [J].

Takada, A ;

Kuboki, N ;

Okazaki, K ;

Ninomiya, A ;

Tanaka, H ;

Ozaki, H ;

Itamura, S ;

Nishimura, H ;

Enami, M ;

Tashiro, M ;

Shortridge, KF ;

Kida, H .

JOURNAL OF VIROLOGY, 1999, 73 (10) :8303-8307

← 1 2 3 4 5 →